TUMBARELLO MARIO
Contatti
0577235435 [int.5435]
Attività didattica
ANNO ACCADEMICO DI ESPLETAMENTO: 2026/2027
ANNO ACCADEMICO DI ESPLETAMENTO: 2025/2026
ANNO ACCADEMICO DI ESPLETAMENTO: 2024/2025
Attività di ricerca
Ultime pubblicazioni:
- Tumbarello, M., Giuliano, G., Criscuolo, M., Del Principe, M.I., Papayannidis, C., Fracchiolla, N.S., et al. (2025). Clinical impact of ceftazidime/avibactam on the treatment of suspected or proven infections in a large cohort of patients with haematological malignancies: a multicentre observational real-world study. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 80(2), 386-398 [10.1093/jac/dkae416]. - dettaglio
- Sambri, V., Agnoletti, V., Ambretti, S., Bartoletti, M., Bernaschi, P., Bignami, E.G., et al. (2025). The role of rapid and advanced microbiological methods in critical care: 2025 Emanuele Russo Delphi consensus. CLINICAL MICROBIOLOGY AND INFECTION, 31(12), 1993-2000 [10.1016/j.cmi.2025.08.022]. - dettaglio
- Bassetti, M., Cardone, A., Cardoso, F., Carter, V., Cornely, O.A., Falcone, M., et al. (2025). Can we lower the burden of antimicrobial resistance (AMR) in heavily immunocompromised patients? A narrative review and call to action. INFECTIOUS DISEASES AND THERAPY, 14(9), 2029-2052 [10.1007/s40121-025-01204-4]. - dettaglio
- Rinaldi, M., Rancan, I., Malerba, F., Gatti, M., Ancillotti, L., Tazza, B., et al. (2025). Enterococcus faecium bacteraemia: a multicentre observational study focused on risk factors for clinical and microbiological outcomes. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 80(8), 2247-2256 [10.1093/jac/dkaf197]. - dettaglio
- Lombardi, A., Giacobbe, D.R., Mangioni, D., Mariani, B., Muscatello, A., Muccio, M., et al. (2025). Cefiderocol therapy among immunocompromised adult patients: a descriptive analysis from a prospective, multicentre cohort study. BMC INFECTIOUS DISEASES, 25(1) [10.1186/s12879-025-11573-3]. - dettaglio